1
|
Bao M, Zhang M, Shi H, Liu X, Duan M, Zhuang J, Du X, Qin L, Hui W, Liang R, Wang M, Chen Y, Li D, Yang W, Tang G, Zhang W, Kuang X, Su W, Han Y, Chen L, Xu J, Liu Z, Huang J, Zhao C, Tong H, Hu J, Chen C, Chen X, Xiao Z, Jiang Q. Patient-Reported Outcomes in Young Adults with Myeloproliferative Neoplasms. Acta Haematol 2023; 146:293-306. [PMID: 36812897 DOI: 10.1159/000529750] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2022] [Accepted: 02/13/2023] [Indexed: 02/24/2023]
Abstract
INTRODUCTION Genetic landscape, disease characteristics, and clinical outcomes of young adults with myeloproliferative neoplasms (MPNs) were reported. However, data on patient-reported outcomes (PROs) in young adults with MPNs were rare. METHODS We conducted a multicenter, cross-sectional study to compare the PROs in respondents with thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF) by age at survey, including the young group (18-40 years), middle-aged group (41-60 years), and elderly group (>60 years). RESULTS Of the 1,664 respondents with MPNs, 349 (21.0%) were young including 244 (69.9%) with ET, 34 (9.7%) with PV, and 71 (20.3%) with MF. In multivariate analyses, the young groups with ET and MF were associated with the lowest MPN-10 scores among the 3 age groups; those with MF, highest proportion of reporting negative impact of disease and therapy on their daily life and work. The young groups with MPNs had the highest physical component summary scores but the lowest mental component summary scores in those with ET. The young groups with MPNs were most concerned about fertility; those with ET, treatment-related adverse events and long-term efficacy of treatment. CONCLUSIONS We concluded that young adults with MPNs have different PROs compared with middle-aged and elderly patients.
Collapse
Affiliation(s)
- Mei Bao
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
| | - Mengyu Zhang
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
| | - Hongxia Shi
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
| | - Xiaoli Liu
- Nanfang Hospital, Southern Medical University, Guangzhou, China
| | - Minghui Duan
- Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
| | - Junling Zhuang
- Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
| | - Xin Du
- Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China
| | - Ling Qin
- The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China
| | - Wuhan Hui
- Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Rong Liang
- Xi Jing Hospital, The Fourth Military Medical University, Xi An, China
| | - Meifang Wang
- Second Hospital of Shanxi Medical University, Taiyuan, China
| | - Ye Chen
- Beijing Anzhen Hospital, Capital Medical University, Beijing, China
| | - Dongyun Li
- Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
| | - Wei Yang
- Shengjing Hospital Affiliated to China Medical University, Shenyang, China
| | | | - Weihua Zhang
- First Hospital of Shanxi Medical University, Taiyuan, China
| | - Xia Kuang
- Kaifeng Central Hospital, Kaifeng, China
| | - Wei Su
- Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China
| | - Yanqiu Han
- The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China
| | - Limei Chen
- The First Affiliated Hospital of Xi'an Jiaotong University, Xi An, China
| | - Jihong Xu
- Qiqihar First Hospital, Qiqihar, China
| | - Zhuogang Liu
- Shengjing Hospital Affiliated to China Medical University, Shenyang, China
| | - Jian Huang
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, China
| | - Chunting Zhao
- The Affiliated Hospital of Qingdao University, Qingdao, China
| | - Hongyan Tong
- The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, China
| | - Jianda Hu
- Fujian Medical University Union Hospital, Fuzhou, China
| | | | - Xiequn Chen
- Institute of Hematology and Affiliated Hospital, Medicine School, Northwestern University, Xi An, China
| | - Zhijian Xiao
- Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
| | - Qian Jiang
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
| |
Collapse
|